Scarica l'app Stockscreener
10.76
0.09%
0.010
Drugs Made In America Acquisition Corp Borsa (DMAA) Ultime notizie
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - Vinanet
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsDouble Top - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet
Pfizer Inc. - Encyclopedia Britannica
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - Vinanet
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSynthetic Short - Vinanet
Law firm launches legal inquiries into mergers of LXP, DMAA, PSNL, and FNWD for shareholder protection. - Pluang
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - tradingkey.com
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition II Corp. Unit (DMIIU) Holds Flat at $10.16 Amid Low VolatilityRisk Reward Setups - vinanet.vn
BLZR|Trailblazer Acquisition Corp|Price:10.160| - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
TradingKey - TradingKey
LATA|Galata Acquisition Corp II|Price:10.150|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.710| - TradingKey
WTG|Wintergreen Acquisition Corp|Price:10.490|Chg%:+0.020 - TradingKey
Drugs Made In America Acquisition II Corp. (DMII) Holds Steady at $10.09 Amid SPAC StabilityWMA Signal - Vinanet
DMIIR Rights Remain Flat at $0.08 – Stagnant Trading Reflects Limited ActivityVolatility Smile - vinanet.vn
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) - PR Newswire
Drugs Made In America Acquisition Corp. (DMAA) Amends Merger Agreement With Power Analytics Global Corp – Key Details, Dates, and SEC Filing Information – Minichart - Minichart
Drugs Made In America (NASDAQ: DMAA) tightens PAGC merger terms and sponsor economics - Stock Titan
Drugs Made In America amends merger agreement terms - TipRanks
Drugs Made In America Acquisition Revises PAGC Merger; Sets $30M Target Cash and Founder Share Forfeiture - TradingView
Drugs Made In America Acquisition II Corp. Right (DMIIR): Trading Flat at $0.08 Amid Low ActivityMomentum Trade - Vinanet
DMAAR Rights Hover Near Flat at $0.11 – Support and Resistance Levels TightenALMA Signal - vinanet.vn
DMAAR Rights Decline Sharply, Testing Critical Support at $0.10Breakout Trade - vinanet.vn
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to earnings forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - tradingview.com
0.10%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):